Literature DB >> 2474677

Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes.

K Taniguchi1, K Nishikawa, T Urasawa, S Urasawa, K Midthun, A Z Kapikian, M Gorziglia.   

Abstract

In our previous study (K. Taniguchi, Y. Morita, T. Urasawa, and S. Urasawa, J. Virol. 62:2421-2426, 1987) in which the cross-reactive neutralization epitopes on VP4 of human rotaviruses were analyzed, one strain, K8, was found to bear unique VP4 neutralization epitopes. This strain, which belongs to subgroup II and serotype 1, was not neutralized by any of six anti-VP4 neutralizing monoclonal antibodies which reacted with human rotavirus strains of serotypes 1, 3, and 4 or serotypes 1 through 4. We determined the complete nucleotide sequence of the gene encoding VP4 of strain K8 by primer extension. The VP4 gene is 2,359 base pairs in length, with 5' and 3' noncoding regions of 9 and 25 nucleotides, respectively. The gene contains a long open reading frame of 2,325 bases capable of coding for a protein of 775 amino acids. When compared with those of other human rotaviruses, VP4 of strain K8 had an insertion of one amino acid after residue 135, as found in simian rotavirus strains, and in addition, it had a deletion of one amino acid (residue 575). The amino acid homology of VP4 of strain K8 and those of other virulent human rotaviruses was only 60 to 70%. This was unusual, since over 90% VP4 homology has been found among the other virulent human rotavirus strains. In contrast, the VP7 amino acid sequence of the K8 strain was quite similar (over 98% homology) to those of other serotype 1 human rotaviruses. Thus, the K8 strain appears to have a unique VP4 gene previously not described.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474677      PMCID: PMC251016     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections.

Authors:  M Gorziglia; K Green; K Nishikawa; K Taniguchi; R Jones; A Z Kapikian; R M Chanock
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

2.  Proteolytic enhancement of rotavirus infectivity: molecular mechanisms.

Authors:  M K Estes; D Y Graham; B B Mason
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

3.  Structural polypeptides of simian rotavirus SA11 and the effect of trypsin.

Authors:  R T Espejo; S López; C Arias
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

4.  Use of transcription probes for genotyping rotavirus reassortants.

Authors:  J Flores; H B Greenberg; J Myslinski; A R Kalica; R G Wyatt; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1982-09       Impact factor: 3.616

5.  Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus.

Authors:  H B Greenberg; J Flores; A R Kalica; R G Wyatt; R Jones
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

6.  Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1981-10-24       Impact factor: 16.971

7.  Three human rotavirus serotypes demonstrated by plaque neutralization of isolated strains.

Authors:  S Urasawa; T Urasawa; K Taniguchi
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

8.  Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.

Authors:  T Vesikari; E Isolauri; E D'Hondt; A Delem; F E André; G Zissis
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

9.  Electrophoretic analysis of RNA segments of human rotaviruses cultivated in cell culture.

Authors:  K Taniguchi; S Urasawa; T Urasawa
Journal:  J Gen Virol       Date:  1982-05       Impact factor: 3.891

10.  Induction of cross-reactive serum neutralizing antibody to human rotavirus in calves after in utero administration of bovine rotavirus.

Authors:  R G Wyatt; A Z Kapikian; C A Mebus
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  27 in total

1.  Rotavirus strains bearing genotype G9 or P[9] recovered from Brazilian children with diarrhea from 1997 to 1999.

Authors:  N Santos; E M Volotão; C C Soares; M C Albuquerque; F M da Silva; T R de Carvalho; C F Pereira; V Chizhikov; Y Hoshino
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Human rotavirus strain with unique VP4 neutralization epitopes as a result of natural reassortment between members of the AU-1 and Wa genogroups.

Authors:  O Nakagomi; E Kaga; T Nakagomi
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Identification of human and bovine rotavirus serotypes by polymerase chain reaction.

Authors:  K Taniguchi; F Wakasugi; Y Pongsuwanna; T Urasawa; S Ukae; S Chiba; S Urasawa
Journal:  Epidemiol Infect       Date:  1992-10       Impact factor: 2.451

4.  Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.

Authors:  N Kobayashi; K Taniguchi; T Urasawa; S Urasawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Nucleotide sequence of VP4 and VP7 genes of human rotaviruses with subgroup I specificity and long RNA pattern: implication for new G serotype specificity.

Authors:  K Taniguchi; T Urasawa; N Kobayashi; M Gorziglia; S Urasawa
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Species-specific and interspecies relatedness of NSP1 sequences in human, porcine, bovine, feline, and equine rotavirus strains.

Authors:  K Kojima; K Taniguchi; N Kobayashi
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

8.  Rotavirus serotypes and electropherotypes in Finland from 1986 to 1990.

Authors:  L Maunula; C H von Bonsdorff
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Prevalence of serum neutralizing antibody to serotype 9 rotavirus WI61 in children from South America and central Europe.

Authors:  H Brüssow; H F Clark; J Sidoti
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

10.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.